首页 > 最新文献

International journal of anesthetics and anesthesiology最新文献

英文 中文
Sevoflurane but not Propofol Induces Immunomodulatory Effects in Patients Undergoing Aortic Valve Replacement and Cardiopulmonary Bypass 七氟醚而非异丙酚诱导主动脉瓣置换术和体外循环患者的免疫调节作用
Pub Date : 2018-06-30 DOI: 10.23937/2377-4630/1410068
Veiras Sonia, G. R. Rodríguez, S. Tomás, R. Javier, Baluja Aurora, A. Julian
Background: Volatile anaesthetics, most of all sevoflurane, have been described as providers of myocardial preconditioning, but few articles are focused on immunomodulatory effects of these agents. We aimed to study the effects of different anaesthetic procotols with sevoflurane and propofol on immunomodulation in patients undergoing cardiopulmonary bypass (CBP). Methods: Twenty-five patients scheduled for aortic valve replacement undergoing CBP were studied and divided in three groups depending on anaesthetic protocol: sevoflurane for induction, maintenance and CBP period (group 1); propofol for induction, maintenance and CBP period (group 2); propofol for induction and CBP period and sevoflurane for maintenance before and after CBP (group 3). Blood samples were obtained at baseline, immediately after sternal closure, 24 hours, 72 hours and 7 days after surgery. TLR2 and TLR4 expression were measured in monocytes and lymphocytes, and serum levels of tumoral necrosis factor α (TNFα), Cystatin C, Reactive C Protein (PCR), Propeptide Brain Natriuretic Protein (Pro-BNP) and Interleukin (IL) 6, IL-2R and IL-8 were analyzed. Conclusions: Compared with propofol, sevoflurane anaesthesia was associated to lower expression of TLR2 in monocytes and lower serum levels of inflammatory mediators.
背景:挥发性麻醉剂,主要是七氟醚,被描述为心肌预处理的提供者,但很少有文章关注这些药物的免疫调节作用。我们的目的是研究七氟醚和异丙酚不同麻醉方案对体外循环(CBP)患者免疫调节的影响。方法:选取25例主动脉瓣置换术行CBP的患者为研究对象,根据麻醉方案分为三组:七氟醚用于诱导、维持和CBP周期(1组);异丙酚用于诱导、维持和CBP期间(组2);异丙酚用于诱导和CBP期间,七氟醚用于CBP前后的维持(组3)。分别于基线、关闭胸骨后立即、术后24小时、72小时和7天采集血样。检测TLR2和TLR4在单核细胞和淋巴细胞中的表达,分析血清肿瘤坏死因子α (TNFα)、胱抑素C、反应C蛋白(PCR)、前肽脑利钠蛋白(Pro-BNP)和白细胞介素(IL) 6、IL- 2r、IL-8的水平。结论:与异丙酚相比,七氟醚麻醉可降低单核细胞中TLR2的表达,降低血清炎症介质水平。
{"title":"Sevoflurane but not Propofol Induces Immunomodulatory Effects in Patients Undergoing Aortic Valve Replacement and Cardiopulmonary Bypass","authors":"Veiras Sonia, G. R. Rodríguez, S. Tomás, R. Javier, Baluja Aurora, A. Julian","doi":"10.23937/2377-4630/1410068","DOIUrl":"https://doi.org/10.23937/2377-4630/1410068","url":null,"abstract":"Background: Volatile anaesthetics, most of all sevoflurane, have been described as providers of myocardial preconditioning, but few articles are focused on immunomodulatory effects of these agents. We aimed to study the effects of different anaesthetic procotols with sevoflurane and propofol on immunomodulation in patients undergoing cardiopulmonary bypass (CBP). Methods: Twenty-five patients scheduled for aortic valve replacement undergoing CBP were studied and divided in three groups depending on anaesthetic protocol: sevoflurane for induction, maintenance and CBP period (group 1); propofol for induction, maintenance and CBP period (group 2); propofol for induction and CBP period and sevoflurane for maintenance before and after CBP (group 3). Blood samples were obtained at baseline, immediately after sternal closure, 24 hours, 72 hours and 7 days after surgery. TLR2 and TLR4 expression were measured in monocytes and lymphocytes, and serum levels of tumoral necrosis factor α (TNFα), Cystatin C, Reactive C Protein (PCR), Propeptide Brain Natriuretic Protein (Pro-BNP) and Interleukin (IL) 6, IL-2R and IL-8 were analyzed. Conclusions: Compared with propofol, sevoflurane anaesthesia was associated to lower expression of TLR2 in monocytes and lower serum levels of inflammatory mediators.","PeriodicalId":90855,"journal":{"name":"International journal of anesthetics and anesthesiology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42863984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Pain Management in a Child: A Case Report of 46-Days of Popliteal Sciatic Nerve Catheter 儿童急性疼痛的处理:46天腘窝坐骨神经导管1例报告
Pub Date : 2018-06-30 DOI: 10.23937/2377-4630/1410063
Laurent Hertz, C. Sola, P. D. L. Arena, C. Dadure
Background: The use of perineural catheter for more than 72 hours is rare in perioperative practice, but was especially reported for chronic pain, oncologic related pain or palliative care. The main concern remains the risk of neurological or infectious complication. No guideline clearly specifies the maximum duration of perineural catheter maintenance and the safety of long-term catheters is discussed. Case report: We described the case of an 11-year-old boy who suffered a serious injury on his foot. An ultrasound guided sciatic nerve block was performed, with placement of a non-tunneled perineural catheter. The catheter could be used for 46 days with an excellent efficiency both for analgesia (continuous infusion) and anesthesia (additional bolus for surgical procedure). No infectious or neurological related complication to regional anesthesia was notified. Conclusion: This case demonstrates all the benefits that can be expected by long-term perineural catheter, even if it should be managed with great caution and after careful assessment of the risk-benefit balance. number of days before removal of the catheter with an increased risk after 3 days of catheter maintenance [2]. But only few transient and no major neurologic complications were reported [2]. In pediatric, PNBC are often used for postoperative analgesia after orthopedic or general surgery and are typically removed after only 2-3 days. Long term used of PNBC have yet been described for control of chronic pain, oncologic related pain or palliative care in young adults and children [3-5]. We present the case of a child who required the use of a PNBC over a long period of 46 days for perioperative pain management. The child and his family consented to the anonymous publication of this case. Description of the Case An 11-years-old boy, weighting 38 kg, without medical or surgical history, was admitted to our unit after a motor vehicle-pedestrian trauma. The child presented a faciocranial trauma with an initial loss of consciousness but a Glasgow score of 14 at the arrival of medical assistance. A fracture of the right horizontal branch of the mandibular corpus was diagnosed and treated by surgical osteosynthesis. Moreover, there was a severe injury with a large soft tissue defect extending from the internal malleolus to the second phalangeal of the right hallux and musculotendinous and osseous exposure. No vascular compromise was noted and the limited initial neurological exam was not able to objectify significant nerve injury or deficit. The patient complained of diffuse pain. However, shocked by the accident, it was not possible to assess the level of his pain. It was decided to treat him by sedation-analgesia with ketamine. Surgical CASe RePoRt
背景:围手术期使用神经导管超过72小时的情况很少见,但在慢性疼痛、肿瘤相关疼痛或姑息治疗中尤其有报道。主要关注的仍然是神经系统或感染性并发症的风险。没有明确规定会阴导管维护的最长持续时间的指南,也没有讨论长期导管的安全性。病例报告:我们描述了一个11岁男孩的案例,他的脚受了重伤。在超声引导下进行坐骨神经阻滞,并放置非隧道式神经导管。该导管可使用46天,在镇痛(持续输注)和麻醉(外科手术的额外推注)方面都具有良好的效率。未报告区域麻醉的感染性或神经系统相关并发症。结论:该病例证明了长期神经导管可以预期的所有益处,即使应该非常谨慎地进行管理,并在仔细评估风险-收益平衡后进行管理。移除导管前的天数,导管维护3天后风险增加[2]。但仅报告了少数短暂性神经系统并发症,且无重大神经系统并发症[2]。在儿科,PNBC通常用于骨科或普通外科手术后的术后镇痛,通常仅在2-3天后取出。PNBC的长期使用尚未被描述用于控制年轻成人和儿童的慢性疼痛、肿瘤相关疼痛或姑息治疗[3-5]。我们介绍了一个需要在46天的长时间内使用PNBC进行围手术期疼痛管理的儿童的案例。孩子和他的家人同意匿名公布这一案件。病例描述一名11岁男孩,体重38公斤,无病史或手术史,因机动车行人受伤入院。这名儿童出现了面颅创伤,最初失去意识,但在医疗救助到达时,格拉斯哥评分为14。诊断和治疗了一例下颌骨右侧水平支骨折。此外,还有一个严重的损伤,从内踝延伸到右拇第二指骨的大的软组织缺损,以及肌肉腱和骨暴露。没有发现血管损伤,有限的初步神经检查无法客观化显著的神经损伤或缺损。病人抱怨弥漫性疼痛。然而,由于对事故感到震惊,无法评估他的疼痛程度。决定用氯胺酮进行镇静镇痛治疗。外科病例RePoRt
{"title":"Acute Pain Management in a Child: A Case Report of 46-Days of Popliteal Sciatic Nerve Catheter","authors":"Laurent Hertz, C. Sola, P. D. L. Arena, C. Dadure","doi":"10.23937/2377-4630/1410063","DOIUrl":"https://doi.org/10.23937/2377-4630/1410063","url":null,"abstract":"Background: The use of perineural catheter for more than 72 hours is rare in perioperative practice, but was especially reported for chronic pain, oncologic related pain or palliative care. The main concern remains the risk of neurological or infectious complication. No guideline clearly specifies the maximum duration of perineural catheter maintenance and the safety of long-term catheters is discussed. Case report: We described the case of an 11-year-old boy who suffered a serious injury on his foot. An ultrasound guided sciatic nerve block was performed, with placement of a non-tunneled perineural catheter. The catheter could be used for 46 days with an excellent efficiency both for analgesia (continuous infusion) and anesthesia (additional bolus for surgical procedure). No infectious or neurological related complication to regional anesthesia was notified. Conclusion: This case demonstrates all the benefits that can be expected by long-term perineural catheter, even if it should be managed with great caution and after careful assessment of the risk-benefit balance. number of days before removal of the catheter with an increased risk after 3 days of catheter maintenance [2]. But only few transient and no major neurologic complications were reported [2]. In pediatric, PNBC are often used for postoperative analgesia after orthopedic or general surgery and are typically removed after only 2-3 days. Long term used of PNBC have yet been described for control of chronic pain, oncologic related pain or palliative care in young adults and children [3-5]. We present the case of a child who required the use of a PNBC over a long period of 46 days for perioperative pain management. The child and his family consented to the anonymous publication of this case. Description of the Case An 11-years-old boy, weighting 38 kg, without medical or surgical history, was admitted to our unit after a motor vehicle-pedestrian trauma. The child presented a faciocranial trauma with an initial loss of consciousness but a Glasgow score of 14 at the arrival of medical assistance. A fracture of the right horizontal branch of the mandibular corpus was diagnosed and treated by surgical osteosynthesis. Moreover, there was a severe injury with a large soft tissue defect extending from the internal malleolus to the second phalangeal of the right hallux and musculotendinous and osseous exposure. No vascular compromise was noted and the limited initial neurological exam was not able to objectify significant nerve injury or deficit. The patient complained of diffuse pain. However, shocked by the accident, it was not possible to assess the level of his pain. It was decided to treat him by sedation-analgesia with ketamine. Surgical CASe RePoRt","PeriodicalId":90855,"journal":{"name":"International journal of anesthetics and anesthesiology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48866688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Long-Term Function, Pain and Medication Use Outcomes of Radiofrequency Ablation for Lumbar Facet Syndrome. 射频消融术治疗腰椎关节突综合征的长期功能、疼痛和用药结果。
Pub Date : 2015-01-01 DOI: 10.23937/2377-4630/2/2/1028
Zachary L McCormick, Benjamin Marshall, Jeremy Walker, Robert McCarthy, David R Walega

Objective: Radiofrequency ablation (RFA) of the medial branch nerves for facet-mediated low back pain demonstrates clinical benefit for 6-12 months and possibly up to 2 years. This study investigated function, pain, and medication use outcomes of RFA for lumbar facet syndrome in a cohort with long-term follow-up.

Methods: Individuals evaluated in a tertiary academic pain practice between January, 2007-December, 2013, 18-60 years of age, with a clinical and radiologic diagnosis of lumbar facet syndrome, who underwent ≥1set of diagnostic medial branch blocks with resultant >75% pain relief and subsequent RFA were included. Outcomes measured were the proportion of individuals who reported ≥50% improvement in function, ≥50% improvement in pain; change in median NRS pain score, daily morphine equivalent consumption (DME), Medication Quantification Scale III (MSQ III) score and procedure complications.

Results: Sixty-two consecutive individuals with a median age and 25%-75% interquartile range (IQR) of 34 years (35, 52) met inclusion criteria. Seven individuals were lost to follow-up. Duration of pain was <2 years in 42%, 2-5 years in 40%, >5 years in 18% of individuals. Median duration of follow-up was 39 months (16, 60). Function and pain improved by ≥50% in 58% (CI 45%, 71%) and 53% (CI 40%, 66%) of individuals, respectively. The median reduction in MQS III score was 3.4 points (0, 8.8). No complications occurred in this cohort.

Conclusions: This study demonstrates a durable treatment effect of RFA for lumbar facet syndrome at long-term follow-up, as measured by improvement in function, pain, and analgesic use.

目的:射频消融(RFA)内侧支神经治疗面介导的腰痛显示了6-12个月甚至可能长达2年的临床益处。本研究在一个长期随访的队列中调查了RFA治疗腰椎关节突综合征的功能、疼痛和药物使用结果。方法:纳入2007年1月至2013年12月在三级学术疼痛实践中评估的个体,年龄18-60岁,临床和放射学诊断为腰椎关节突综合征,接受≥1组诊断性内侧支阻滞治疗,疼痛缓解>75%,随后进行RFA。测量的结果是报告功能改善≥50%、疼痛改善≥50%的个体比例;NRS疼痛评分中位数、每日吗啡当量消耗量(DME)、用药量化量表III (MSQ III)评分和手术并发症的变化。结果:连续62例患者,年龄中位数为34岁,25%-75%四分位数间距(IQR)为35,52岁,符合纳入标准。7人失去随访。18%的患者疼痛持续时间为5年。中位随访时间为39个月(16,60)。58% (CI 45%, 71%)和53% (CI 40%, 66%)患者的功能和疼痛改善≥50%。MQS III评分中位下降3.4分(0,8.8分)。该队列中未发生并发症。结论:在长期随访中,该研究证明了RFA治疗腰椎关节突综合征的持久疗效,通过改善功能、疼痛和止痛药的使用来衡量。
{"title":"Long-Term Function, Pain and Medication Use Outcomes of Radiofrequency Ablation for Lumbar Facet Syndrome.","authors":"Zachary L McCormick,&nbsp;Benjamin Marshall,&nbsp;Jeremy Walker,&nbsp;Robert McCarthy,&nbsp;David R Walega","doi":"10.23937/2377-4630/2/2/1028","DOIUrl":"https://doi.org/10.23937/2377-4630/2/2/1028","url":null,"abstract":"<p><strong>Objective: </strong>Radiofrequency ablation (RFA) of the medial branch nerves for facet-mediated low back pain demonstrates clinical benefit for 6-12 months and possibly up to 2 years. This study investigated function, pain, and medication use outcomes of RFA for lumbar facet syndrome in a cohort with long-term follow-up.</p><p><strong>Methods: </strong>Individuals evaluated in a tertiary academic pain practice between January, 2007-December, 2013, 18-60 years of age, with a clinical and radiologic diagnosis of lumbar facet syndrome, who underwent ≥1set of diagnostic medial branch blocks with resultant >75% pain relief and subsequent RFA were included. Outcomes measured were the proportion of individuals who reported ≥50% improvement in function, ≥50% improvement in pain; change in median NRS pain score, daily morphine equivalent consumption (DME), Medication Quantification Scale III (MSQ III) score and procedure complications.</p><p><strong>Results: </strong>Sixty-two consecutive individuals with a median age and 25%-75% interquartile range (IQR) of 34 years (35, 52) met inclusion criteria. Seven individuals were lost to follow-up. Duration of pain was <2 years in 42%, 2-5 years in 40%, >5 years in 18% of individuals. Median duration of follow-up was 39 months (16, 60). Function and pain improved by ≥50% in 58% (CI 45%, 71%) and 53% (CI 40%, 66%) of individuals, respectively. The median reduction in MQS III score was 3.4 points (0, 8.8). No complications occurred in this cohort.</p><p><strong>Conclusions: </strong>This study demonstrates a durable treatment effect of RFA for lumbar facet syndrome at long-term follow-up, as measured by improvement in function, pain, and analgesic use.</p>","PeriodicalId":90855,"journal":{"name":"International journal of anesthetics and anesthesiology","volume":"2 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440581/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33332471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 59
期刊
International journal of anesthetics and anesthesiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1